Previous Page  3 / 25 Next Page
Information
Show Menu
Previous Page 3 / 25 Next Page
Page Background

Journal of Transmitted Diseases and Immunity

ISSN: 2573-0320

Page 29

Volume 4

May 10-11, 2018

Frankfurt, Germany

Immunology Research 2018

Tissue Science 2018

JOINT EVENT

2 2

n d

E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n

Immunology and

Evolution of Infectious Diseases

&

1 2

t h

E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n

Tissue Engineering and

Regenerative Medicine

T

he rapid clearance of malaria parasite DNA from

circulation has widely been accepted as a fact without

being systemically investigated. In this longitudinal study,

we examined the duration of PCR positivity as well as the

presence of gametocytes in adult travelers treated for

Plasmodium falciparum

malaria in a malaria-free setting,

using microscopy, species-specific qPCR, merozoite surface

protein 2 (msp2)-genotyping PCR, and gametocyte-specific

qPCR. Venous blood was collected at the time of admission

and prospectively up to one year. Patients were treated with

a full regimen of six doses of artemether-lumefantrine (AL).

In 31 successfully treated individuals, asexual parasites were

seen by microscopy until two days after treatment, whereas

parasite DNA was detected by msp2- and species-specific

PCR up to days 31 and 42, respectively. Statistical modelling

predicted 26% (± 0•05 SE) species-specific PCR positivity until

day 40 and estimated 48 days for all samples to become PCR

negative. Gametocytes were detected by microscopy and PCR

latest two days after treatment. CT values correlated well with

microscopy-defined parasite densities before but not after

treatment started. Duration of PCR positivity was correlated

neither with the initial (asexual) parasite densities nor with

the initial presence of gametocytes.These results reveal

that PCR positivity can persist several weeks after treatment

without evidence of viable sexual or asexual parasites, and

that the removal of dead parasites and their debris is not as

rapid as it is believed, indicating that PCR may overestimate

post-treatment parasite prevalence in epidemiological studies,

and underestimate drug efficiency in clinical management and

trials. This report underlines an important diagnostic matter

essentially in infectious diseases and particularly in malaria,

and points out the need for detection tool as sensitive as PCR

and as accurate as microscopy

Biography

She holds a BSc. in microbiology and PhD in immunology and has about 17

years of research experience in infectious diseases and vaccines. Her re-

search path started as research assistant at Pasteur Institute of Iran, where

she was involved in recombinant vaccine studies against Leishmania major,

and assisted the group leader to establish and run the “Molecular Immunol-

ogy and Vaccine lab”. She fulfilled her PhD studies at Stockholm University

on the general topic of “Human genetic factors involved in immunity to ma-

laria”, while contributing to allergy studies as well. As Postdoctoral research-

er and Assistant Professor her research focus turned towards genetic diver-

sity of malaria parasite in relation to transmission intensity and prospective

studies of malaria in travelers. Years of engagement with tropical diseases

provided her with experience of filed study as well as broad collaborative

network. Beside academic education, she schooled for ICH-GCP, Pharma-

covigilance-Drug Safety, GMP, and coaching-leadership.

manijehvafa@gmail.com

Detection of malaria parasites after treatment in travelers:

A 12-months longitudinal study and statistical modelling

analysis

Manijeh Vafa Homann

Karolinska Institutet, Sweden

Manijeh Vafa Homann, J Transm Dis Immun 2018, Volume 2

DOI: 10.21767/2573-0320-C2-005